A
Alcista
Alcista · 25%CHWY
$56.49
Precio del escenario
$20.970
-0.336 (-1.60%)Al cierre
Loading chart…
- Máximo
- 21.370
- Apertura
- 21.340
- Precio medio ponderado por volumen
- 21.01
- Volumen
- 7.68M
- Capitalización
- 12.66B
- Mínimo
- 20.685
- Importe
- 161.43M
- EV/EBITDA, TTM
- 18.28
Chewy, Inc. provides pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. The Company offers websites and mobile applications which allow pet parents to manage pets’ health, wellness, and merchandise needs. It offers customers approximately 190,000 products and service offerings. It operates fulfillment centers located in the United States and Canada. It offers a range of educational media, such as blogs, videos, and tutorials on the website, Chewy.com/education and pet health focused content on the website, PetMD.com. It operates eight veterinary clinics under the brand name Chewy Vet Care, offering pet health services including routine appointments, urgent care and surgery. Its trademarks include American Journey, Blue Box Event, CarePlus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Get Real, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo.
Análisis de IA of Chewy Inc (CHWY)
MantenerChewy Inc is currently trading at $20.97, which is below several analyst price targets, including $28 from Mizuho and $30 from Goldman Sachs. However, the stock has a high RSI of 76.232, indicating it may be overbought in the short term. Additionally, insider selling has surged by 2640.37% recently, which raises concerns about insider confidence in the stock's future performance. Given these mixed signals, it may be prudent to hold rather than buy at this time.
Métricas de valoración
El PER previsto actual de Chewy Inc (CHWY) es 12.79, frente a su media de 5 años de 66.08.
Escenarios de precio de Alphio AI para CHWY
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con CHWY en cartera
Cronología de eventos
Noticias
Preguntas frecuentes sobre CHWY, respondidas por Alphio AI
Chewy, Inc. provides pet food and treats, pet supplies and pet medications, other pet-health products, and pet services. The Company offers websites and mobile applications which allow pet parents to manage pets’ health, wellness, and merchandise needs. It offers customers approximately 190,000 products and service offerings. It operates fulfillment centers located in the United States and Canada. It offers a range of educational media, such as blogs, videos, and tutorials on the website, Chewy.com/education and pet health focused content on the website, PetMD.com. It operates eight veterinary clinics under the brand name Chewy Vet Care, offering pet health services including routine appointments, urgent care and surgery. Its trademarks include American Journey, Blue Box Event, CarePlus, Chewy, Chewy.com, Chewy Vet Care, Dr. Lyon’s, Frisco, Get Real, Goody Box, Onguard, PetMD, PracticeHub, Tiny Tiger, True Acre Farms, Tylee’s, Vibeful, and The Zoo. It operates in the Consumer Cyclicals sector (RETAIL-CATALOG & MAIL-ORDER HOUSES industry).
Chewy Inc is currently trading at $20.97, which is below several analyst price targets, including $28 from Mizuho and $30 from Goldman Sachs. However, the stock has a high RSI of 76.232, indicating it may be overbought in the short term. Additionally, insider selling has surged by 2640.37% recently, which raises concerns about insider confidence in the stock's future performance. Given these mixed signals, it may be prudent to hold rather than buy at this time.
Comunidad
Más ↗
$CHWY Q2 '27 Earnings Results & Recap • Reported GAAP EPS of $0.36, up 9.09% YoY • Reported revenue of $3.33B, up 7.28% YoY • Chewy, Inc. management expressed confidence in raising the full-year revenue and profitability outlook, though no specific quantified numeric guidance ranges were provided for the remainder of fiscal 2026.
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.